secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K/A
Filed at:   2024-08-26T23:59:59+00:00
Accession:  0001493152-24-033873
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Tevogen Bio raises $6M via Series C Preferred Stock; two closings Aug 30 & Sept 16
--------------------------------------------------------------------------------

- Investor to purchase 600 shares of Series C Preferred Stock for $6.0 million aggregate.
- First closing of $4.0M on Aug 30, 2024; second closing of $2.0M on Sept 16, 2024.
- Conversion price: VWAP over 30 trading days prior to conversion, floor $0.6172; subject to 9.99% beneficial ownership limit.
- Preferred stock carries 7.5% annual cumulative dividend, payable in kind or cash, starting Sept 30, 2024.
- Company has call right after five years; stock is non-voting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000149315224033873/0001493152-24-033873-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000149315224033873/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-033873

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer